Business Description
![BerGenBio ASA BerGenBio ASA logo](https://static.gurufocus.com/logos/0C0000B8RH.png?14)
BerGenBio ASA
ISIN : NO0013251173
Compare
Compare
Traded in other countries / regions
BGBIO.Norway7BG0.Germany0RU5.UKBGBIOO.SwedenBRRGF.USA IPO Date
2019-02-05Description
BerGenBio ASA is a clinical-stage biopharmaceutical Company focused on developing novel medicines for aggressive diseases. The company's clinical asset, bemcentinib, targeting the receptor tyrosine kinase AXL, is currently in development in a Ph1b/2a study in 1L STK 11 mutated NSCLC and preclinical development for severe respiratory infections.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 478.75 | |||||
Equity-to-Asset | 0.8 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.03 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -66.9 | |||||
3-Year EBITDA Growth Rate | 64.5 | |||||
3-Year EPS without NRI Growth Rate | 64.7 | |||||
3-Year FCF Growth Rate | 61.2 | |||||
3-Year Book Growth Rate | -80.7 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.36 | |||||
9-Day RSI | 39.07 | |||||
14-Day RSI | 41.98 | |||||
6-1 Month Momentum % | -43.91 | |||||
12-1 Month Momentum % | 24.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.05 | |||||
Quick Ratio | 5.05 | |||||
Cash Ratio | 4.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -198.5 | |||||
Shareholder Yield % | -32.25 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -31124.18 | |||||
Net Margin % | -29828.22 | |||||
FCF Margin % | -32306.67 | |||||
ROE % | -104.26 | |||||
ROA % | -81.22 | |||||
ROIC % | -728.93 | |||||
ROC (Joel Greenblatt) % | -51504.22 | |||||
ROCE % | -106.34 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 578.95 | |||||
PB Ratio | 2.45 | |||||
Price-to-Tangible-Book | 2.42 | |||||
EV-to-EBIT | -1.97 | |||||
EV-to-Forward-EBIT | -1.57 | |||||
EV-to-EBITDA | -1.98 | |||||
EV-to-Forward-EBITDA | -1.57 | |||||
EV-to-Revenue | 600.02 | |||||
EV-to-Forward-Revenue | 1563.05 | |||||
EV-to-FCF | -1.87 | |||||
Price-to-Net-Current-Asset-Value | 2.42 | |||||
Price-to-Net-Cash | 2.71 | |||||
Earnings Yield (Greenblatt) % | -50.76 | |||||
FCF Yield % | -38.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BerGenBio ASA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.045 | ||
EPS (TTM) (€) | -0.431 | ||
Beta | 50.63 | ||
Volatility % | 153.88 | ||
14-Day RSI | 41.98 | ||
14-Day ATR (€) | 0.04543 | ||
20-Day SMA (€) | 0.97875 | ||
12-1 Month Momentum % | 24.34 | ||
52-Week Range (€) | 0.75 - 3 | ||
Shares Outstanding (Mil) | 39.09 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BerGenBio ASA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BerGenBio ASA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
BerGenBio ASA Frequently Asked Questions
What is BerGenBio ASA(FRA:7BG0)'s stock price today?
The current price of FRA:7BG0 is €0.92. The 52 week high of FRA:7BG0 is €3.00 and 52 week low is €0.75.
When is next earnings date of BerGenBio ASA(FRA:7BG0)?
The next earnings date of BerGenBio ASA(FRA:7BG0) is 2024-11-13.
Does BerGenBio ASA(FRA:7BG0) pay dividends? If so, how much?
BerGenBio ASA(FRA:7BG0) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |